Cite
MLA Citation
Huakun Lv et al.. “Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9–45 years of age: A phase 3 open-label study.” Vaccine, vol. 40, no. 23, 2022, pp. 3263–3271. http://access.bl.uk/ark:/81055/vdc_100155018033.0x00003c